Literature DB >> 30598875

Atrophied brain lesion volume, a magnetic resonance imaging biomarker for monitoring neurodegenerative changes in multiple sclerosis.

Robert Zivadinov1,2, Niels Bergsland1, Michael G Dwyer1.   

Abstract

Entities:  

Year:  2018        PMID： 30598875      PMCID： PMC6288055          DOI： 10.21037/qims.2018.11.01

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN： 2223-4306


× No keyword cloud information.
  7 in total

1.  MRI biomarkers of disease progression in multiple sclerosis: old dog, new tricks?

Authors:  Yael Barnett; Justin Y Garber; Michael H Barnett
Journal:  Quant Imaging Med Surg       Date:  2020-02

2.  The association of myelination in the internal capsule with iron deposition in the basal ganglia in macaques: a magnetic resonance imaging study.

Authors:  Run Pu; Zhe Wu; Wenwen Yu; Hongjian He; Zuofu Zhou; Zheng Wang; Jianhui Zhong
Journal:  Quant Imaging Med Surg       Date:  2020-07

Review 3.  Current and Future Biomarkers in Multiple Sclerosis.

Authors:  Jennifer Yang; Maysa Hamade; Qi Wu; Qin Wang; Robert Axtell; Shailendra Giri; Yang Mao-Draayer
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

4.  Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis.

Authors:  Antonia Valentina Genovese; Jesper Hagemeier; Niels Bergsland; Dejan Jakimovski; Michael G Dwyer; Deepa P Ramasamy; Alexis A Lizarraga; David Hojnacki; Channa Kolb; Bianca Weinstock-Guttman; Robert Zivadinov
Journal:  Radiology       Date:  2019-09-24       Impact factor: 11.105

5.  Systematic review of prediction models in relapsing remitting multiple sclerosis.

Authors:  Fraser S Brown; Stella A Glasmacher; Patrick K A Kearns; Niall MacDougall; David Hunt; Peter Connick; Siddharthan Chandran
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

6.  Consensus on early detection of disease progression in patients with multiple sclerosis.

Authors:  José E Meca-Lallana; Bonaventura Casanova; Alfredo Rodríguez-Antigüedad; Sara Eichau; Guillermo Izquierdo; Carmen Durán; Jordi Río; Miguel Ángel Hernández; Carmen Calles; José M Prieto-González; José Ramón Ara; Dionisio F Uría; Lucienne Costa-Frossard; Antonio García-Merino; Celia Oreja-Guevara
Journal:  Front Neurol       Date:  2022-07-28       Impact factor: 4.086

7.  Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.

Authors:  Marcus Sucksdorff; Markus Matilainen; Jouni Tuisku; Eero Polvinen; Anna Vuorimaa; Johanna Rokka; Marjo Nylund; Eero Rissanen; Laura Airas
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.